Shopping Cart 0
Cart Subtotal
AED 0

MolMed SpA (MLM) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 1101

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 2202

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 3303

Details

Summary

MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of high-risk hematological malignancies, eliminating post-transplant immunosuppression prophylaxis, inducing a rapid immune reconstitution; NGR-hTNF, a therapeutic agent showing anti-tumor activity for solid tumors; and CAR-CD44v6, an immuno-gene therapy project for haematological malignancies and several epithelial tumours. The company also conducts cell and gene therapy projects such as development and the validation of the manufacturing process and control strategy, cGMP production of clinical-grade viral vectors and manufacturing of patient-specific genetically engineered cells. Molmed is headquartered in Milano, Italy.

MolMed SpA Key Recent Developments

Sep 24,2018: MolMed: Carlo Incerti succeeds to Claudio Bordignon as chairman of the board. Salvatore Calabrese appointed officer responsible for the preparation of corporate financial reports

Sep 11,2018: MolMed names Mr. Salvatore Calabrese Chief Financial Officer

Jul 30,2018: MolMed approves results at June 30th 2018

Jun 29,2018: MolMed: resignation of the Officer Responsible for the preparation of corporate financial reports

Jun 22,2018: MolMed and Orchard Therapeutics extend their collaboration in the field of gene therapy for rare diseases

This comprehensive SWOT profile of MolMed SpA provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MolMed SpA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

MolMed SpA-Key Information

MolMed SpA-Overview

MolMed SpA-Key Employees

MolMed SpA-Key Employee Biographies

MolMed SpA-Key Operational Heads

MolMed SpA-Major Products and Services

MolMed SpA-History

MolMed SpA-Company Statement

MolMed SpA-Locations And Subsidiaries

MolMed SpA-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

MolMed SpA-Business Description

MolMed SpA-Corporate Strategy

MolMed SpA-SWOT Analysis

SWOT Analysis-Overview

MolMed SpA-Strengths

MolMed SpA-Weaknesses

MolMed SpA-Opportunities

MolMed SpA-Threats

MolMed SpA-Key Competitors

Section 3-Company Financial Performance Charts

MolMed SpA-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

MolMed SpA, Performance Chart

MolMed SpA, Ratio Charts


List Of Table

List of Tables

MolMed SpA, Key Information

MolMed SpA, Key Ratios

MolMed SpA, Share Data

MolMed SpA, Major Products and Services

MolMed SpA, History

MolMed SpA, Key Employees

MolMed SpA, Key Employee Biographies

MolMed SpA, Key Operational Heads

MolMed SpA, Other Locations

MolMed SpA, Subsidiaries

MolMed SpA, Key Manufacturing facilities

MolMed SpA, Key Competitors

MolMed SpA, SWOT Analysis

MolMed SpA, Ratios based on current share price

MolMed SpA, Annual Ratios

MolMed SpA, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

MolMed SpA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Company Profile

Company Profile Title

Summary

MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of high-risk hematological malignancies, eliminating post-transplant immunosuppression prophylaxis, inducing a rapid immune reconstitution; NGR-hTNF, a therapeutic agent showing anti-tumor activity for solid tumors; and CAR-CD44v6, an immuno-gene therapy project for haematological malignancies and several epithelial tumours. The company also conducts cell and gene therapy projects such as development and the validation of the manufacturing process and control strategy, cGMP production of clinical-grade viral vectors and manufacturing of patient-specific genetically engineered cells. Molmed is headquartered in Milano, Italy.

MolMed SpA Key Recent Developments

Sep 24,2018: MolMed: Carlo Incerti succeeds to Claudio Bordignon as chairman of the board. Salvatore Calabrese appointed officer responsible for the preparation of corporate financial reports

Sep 11,2018: MolMed names Mr. Salvatore Calabrese Chief Financial Officer

Jul 30,2018: MolMed approves results at June 30th 2018

Jun 29,2018: MolMed: resignation of the Officer Responsible for the preparation of corporate financial reports

Jun 22,2018: MolMed and Orchard Therapeutics extend their collaboration in the field of gene therapy for rare diseases

This comprehensive SWOT profile of MolMed SpA provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MolMed SpA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Scope

Table of Contents

Section 1-About the Company

MolMed SpA-Key Information

MolMed SpA-Overview

MolMed SpA-Key Employees

MolMed SpA-Key Employee Biographies

MolMed SpA-Key Operational Heads

MolMed SpA-Major Products and Services

MolMed SpA-History

MolMed SpA-Company Statement

MolMed SpA-Locations And Subsidiaries

MolMed SpA-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

MolMed SpA-Business Description

MolMed SpA-Corporate Strategy

MolMed SpA-SWOT Analysis

SWOT Analysis-Overview

MolMed SpA-Strengths

MolMed SpA-Weaknesses

MolMed SpA-Opportunities

MolMed SpA-Threats

MolMed SpA-Key Competitors

Section 3-Company Financial Performance Charts

MolMed SpA-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

MolMed SpA, Performance Chart

MolMed SpA, Ratio Charts


List Of Table

List of Tables

MolMed SpA, Key Information

MolMed SpA, Key Ratios

MolMed SpA, Share Data

MolMed SpA, Major Products and Services

MolMed SpA, History

MolMed SpA, Key Employees

MolMed SpA, Key Employee Biographies

MolMed SpA, Key Operational Heads

MolMed SpA, Other Locations

MolMed SpA, Subsidiaries

MolMed SpA, Key Manufacturing facilities

MolMed SpA, Key Competitors

MolMed SpA, SWOT Analysis

MolMed SpA, Ratios based on current share price

MolMed SpA, Annual Ratios

MolMed SpA, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

MolMed SpA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts